Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis ; volume:16 ; number:1 ; day:23 ; month:9 ; year:2016 ; pages:1-7 ; date:12.2016
BMC cancer ; 16, Heft 1 (23.9.2016), 1-7, 12.2016
- Creator
-
Nakano, Kenji
- Contributor
-
Motoi, Noriko
Tomomatsu, Junichi
Gokita, Tabu
Ae, Keisuke
Tanizawa, Taisuke
Matsumoto, Seiichi
Takahashi, Shunji
SpringerLink (Online service)
- DOI
-
10.1186/s12885-016-2786-z
- URN
-
urn:nbn:de:1111-201610244706
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nakano, Kenji
- Motoi, Noriko
- Tomomatsu, Junichi
- Gokita, Tabu
- Ae, Keisuke
- Tanizawa, Taisuke
- Matsumoto, Seiichi
- Takahashi, Shunji
- SpringerLink (Online service)
Other Objects (12)
Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study
Disease Response to Pazopanib in Follicular Dendritic Cell Sarcoma
Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS)
Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series
Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib
Durable Response to Pazopanib in Recurrent Metastatic Carotid Body Paraganglioma
Spontaneous pneumothorax in metastatic osteosarcoma: a case series
Metastatic biomarkers in synovial sarcoma
Harnessing soft tissue sarcoma with low-dose pazopanib – a matter of blood levels
PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma
Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendothelioma
Metastatic Ewing's Sarcoma in Right Colon
Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study
Disease Response to Pazopanib in Follicular Dendritic Cell Sarcoma
Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS)
Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series
Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib
Durable Response to Pazopanib in Recurrent Metastatic Carotid Body Paraganglioma
Spontaneous pneumothorax in metastatic osteosarcoma: a case series
Metastatic biomarkers in synovial sarcoma
Harnessing soft tissue sarcoma with low-dose pazopanib – a matter of blood levels
PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma
Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendothelioma
Metastatic Ewing's Sarcoma in Right Colon
Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study
Disease Response to Pazopanib in Follicular Dendritic Cell Sarcoma
Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS)
Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series
Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib
Durable Response to Pazopanib in Recurrent Metastatic Carotid Body Paraganglioma
Spontaneous pneumothorax in metastatic osteosarcoma: a case series
Metastatic biomarkers in synovial sarcoma
Harnessing soft tissue sarcoma with low-dose pazopanib – a matter of blood levels
PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma
Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendothelioma